Oxygen breathing therapy for people with severe leg artery blockage
Looks at oxygen therapy use in adults with critical limb ischemia.
Key facts
- Who runs it
- University Hospital, Angers
- Where
- France3 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 15 Apr 2025
- Expected to end
- Dec 2026
- Type of study
- Observational
- Treatments tested
- introduction of oxygen therapy or not
- Record updated
- 15 June 2026
Who can take part
The trial is looking for adults in hospital at the study centre who have chronic permanent (critical) lack of blood flow in the leg or legs. It looks at oxygen therapy given at normal air pressure.
- Age
- 18 Years and older
- Sex
- All sexes can join
- Disease stage
- Chronic permanent ischemia (critical limb ischemia), with or without skin wounds or tissue damage. Patients must be hospitalized in the recruiting centre.
- Biomarker or test result
- Resting TcpO2 (oxygen level measured through the skin) below 30mmHg
- Main reasons for not taking part
- Acute or worsening heart failure
- Acute or worsening breathing failure
- COPD (chronic lung disease) stage III or IV
- Allergy to medical adhesives
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Patient hospitalized in the recruiting centre
- Patient fulfilling the clinical and paraclinical criteria (resting TcpO2 values < 30mmHg) of the definition of chronic permanent ischemia with or without trophic disorders
Who cannot take part
- Patient suffering from acute or decompensated heart or respiratory failure
- Patient suffering from chronic obstructive pulmonary disease (COPD) stage III or IV
- Patient with allergies to medical adhesives
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Critical ischemia limb
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Peripheral arteriopathy disease (PAD) affects 1 million people in France. In its most advanced stage: chronic permanent ischemia also called critical ischemia, the prognosis of patients is burdened with a one-year mortality rate of 30%. Chronic permanent ischemia results from a lack of oxygen supply to the microcirculatory network, responsible for tissue death and the development of trophic disorders. In this context, many studies have focused on the contribution of hyperbaric oxygen therapy, however none demonstrates with certainty its beneficial effect with a heavy set-up for teams and patients. Furthermore, it appears that normobaric oxygen therapy could have its place in this context by temporarily restoring a sufficient level of transcutaneous oxygen. However, even if normobaric oxygen therapy is common practice although empirical for some practitioners, no data demonstrates its real interest. The purpose of this study is therefore to report the proportion, in usual practice, of patients with permanent chronic ischemia of the lower limb(s), benefiting from normobaric oxygen therapy, but also to show the interest of the contribution of this therapy in usual comprehensive management of these patients. This is a pilot study, after which, if the hypothesis is confirmed, it may be proposed to carry out a randomized study, on a large scale, in order to validate the use of normobaric oxygen therapy in the context of chronic permanent ischemia.
The group in the trial
- hospitalized patients suspected of chronic permanent ischemia realizing transcutaneous oxymetry
hospitalized patients suspected of chronic permanent ischemia realizing transcutaneous oxymetry are enroled in the study. The WIfI score is calculated at the inclusion.
Treatment: introduction of oxygen therapy or not
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia
- Plain-language title
- Oxygen breathing therapy for people with severe leg artery blockageGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06238050, who can take part
- Record updated
- 15 June 2026